According to Sientra's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.0230417. At the end of 2023 the company had a P/S ratio of 0.3468.
Year | P/S ratio | Change |
---|---|---|
2023 | 0.3468 | 53.24% |
2022 | 0.2263 | -91.44% |
2021 | 2.64 | -13.5% |
2020 | 3.06 | -42.24% |
2019 | 5.29 | -0.93% |
2018 | 5.34 | -28.43% |
2017 | 7.46 | -2.33% |
2016 | 7.64 | 173.33% |
2015 | 2.80 | -50.06% |
2014 | 5.60 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Edwards Lifesciences EW | 8.46 | 36,615.00% | ๐บ๐ธ USA |
iRadimed IRMD | 8.11 | 35,109.38% | ๐บ๐ธ USA |
Cardiovascular Systems CSII | 3.52 | 15,171.44% | ๐บ๐ธ USA |
West Pharmaceutical WST | 9.08 | 39,326.60% | ๐บ๐ธ USA |